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tisis was reduced in 16 of 20 patients. Complications: pneumonia - 4 
patients, bronchitis - 5. There was no treatment related mortality. The 
complications caused by the photosensitizers were not observed.
Conclusions: Photodynamic therapy with chlorine photosensitizers 
is effective in palliation of inoperable lung cancer and the low rate of 
complications. Patients were not followed up, quality of their life and 
survival rate is estimated.
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New method for delivering cytostatic drugs to the lung: selective 
pulmonary artery perfusion for the treatment of lung cancer
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Introduction: Lung cancer represents a major health problem. Cyto-
static and radio-therapeutic treatment are both limited due to dose-lim-
iting systemic toxicity and surgery due to its invasive nature. Therefore, 
we developed a catheterisation model of selective pulmonary artery 
perfusion (SPAP) combining the properties of isolated lung perfu-
sion and intravenous treatment to achieve higher local drug levels and 
equivalent systemic exposure.
Material and Methods: Sixteen pigs underwent SPAP of the left pul-
monary artery using a clinically applied dose and volume of gemcitabi-
ne (1g/m2 solved in 50mL) administered by a balloon infusion catheter. 
They furthermore underwent left thoracotomy for tissue sampling. 
Three groups were treated with SPAP for two minutes with normal pul-
monary blood ﬂow, 50% and 90% ﬂow reduction by performing partial 
balloon insufﬂation. Another group had SPAP for ten minutes with 
normal pulmonary blood ﬂow. An additional group (n=4) was infused 
intravenously (IV) for thirty minutes using the same dose and volume. 
Concentrations were measured by high-performance liquid chromatog-
raphy and analysed with ANOVA.
Results: Pulmonary peak concentrations (p=0.01) and areas under the 
curve (AUC) (p=0.001) of SPAP for two and ten minutes were signiﬁ-
cantly higher compared to IV while SPAP for ten minutes resulted in 
the highest AUC (p=0.045) compared to SPAP for two minutes. Flow 
reduction during SPAP resulted in inhomogeneous distribution. Liver 
levels, AUC (serum) and wet-to-dry ratios of all SPAP groups were not 
signiﬁcantly different compared to IV. Histological examination did not 
show any signs of acute pulmonary toxicity like oedema or bleeding.
Conclusion: SPAP resulted in higher peak lung concentrations and 
AUC while systemic exposure was comparable with IV. Therefore, 
we advocate SPAP as a new method to be tested clinically to achieve 
down-staging of the tumour (T) and lymph node (N) status in lung 
cancer.
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Sinomenine inhibits proliferation and apoptosis induction in lung 
cancer cells
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Objective: Sinomenine, an alkaloid extract from the Chinese medici-
nal plant Sinomenium acutum, has a wide range of pharmacological 
actions. Here, we examined whether sinomenine possesses anti-lung 
cancer properties. 
Methods: The human A549 lung cancer cell line and the murine Lewis 
lung carcinoma cell line were used in this study. The cells were treated 
with sinomenine (0.1, 0.2, 0.4, 0.625, 1.25 or 2.5 mM) for 24, 48 or 72 
h. Cellular proliferation was evaluated with a CCK-8 assay. Cell cycle 
phase distribution and apoptosis were examined by ﬂow cytometry.
Results: Sinomenine treatment inhibited cellular proliferation (P<0.01) 
in a time and dose-dependent manner. Cell cycle analysis showed that 
the percentage of cells in G1 stage in the sinomenine-treated groups 
was signiﬁcantly greater, while the percentage of cells in S stage was 
signiﬁcantly less than in the control group. The apoptosis assay showed 
that the apoptotic cell rate in the sinomenine-treated groups was sig-
niﬁcantly elevated in a time and dose-dependent manner (P <0.05 vs. 
controls).
Conclusion: Sinomenine can effectively inhibit proliferation of A549 
and Lewis cancer cells. The cell cycle arrest and apoptosis induced by 
sinomenine treatment may underlie, at least in part, the purported anti-
cancer effects of this extract. If so, sinomenine may be developed into 
an effective treatment against lung tumors.
